HUMA stock news
This page provides real-time market news, earnings updates, and company announcements related to Humacyte, Inc. (HUMA).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-06 15:03 EST
Affordability Initiatives Challenge the Trade-Off Between Immediate Remedies and Sustainable Strategies
Bitget-RWA2025-11-16 21:16:10
Humacyte Announces Presentation of Symvess Long-Term Safety and Efficacy Results at VESS Meeting
Finviz2026-02-18 13:06:41
Humacyte To Participate in Upcoming Investor Conferences
Finviz2026-03-02 13:03:58
Humacyte, Inc. (HUMA) Is Viewed Favorably by Analysts: Does This Hold Up?
101 finance2026-03-06 15:37:02
Humacyte Submits Marketing Authorization Application for Symvess in Israel for Vascular Trauma Repair
Finviz2026-03-17 12:03:50
HUMA Drops 19.6%: Sharp Downturn Triggered by $20M Sale Amid Market Turbulence
101 finance2026-03-19 14:48:59
HUMA’s Exclusive Saudi Deal and 25% Share Price Cut: A Sign of Urgency or a Strategic Move?
101 finance2026-03-21 15:27:43
Humacyte’s Strategic Approach: Fundraising and Middle East Momentum Reduce Risks of Binary Clinical Results
101 finance2026-03-22 04:39:50
HUMA: Saudi Exclusive Period and Phase 3 Results Present High-Stakes, High-Confidence Triggers
101 finance2026-03-22 05:00:39
Humacyte Appoints Rick McElheny as Senior Vice President of Business Development
Finviz2026-03-26 12:03:47
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update
Finviz2026-03-27 11:03:57
Humacyte, Inc. (HUMA) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations
101 finance2026-03-27 13:15:40
Humacyte’s VAC Approval Timelines and Pricing Claims Don’t Match in 2025 Earnings Calls
101 finance2026-03-29 06:27:53
Humacyte, Inc. (HUMA) Shares Decline Despite Overall Market Rise: The Reason Explained
101 finance2026-04-01 23:18:49
HUMA Rebounds Close to Support Level—Yet Trading Volume Stays Low
101 finance2026-04-02 19:33:47
Humacyte Submits Marketing Authorization Application for Symvess in Israel for Vascular Trauma Repair
Finviz2026-03-17 12:03:50
HUMA Drops 19.6%: Sharp Downturn Triggered by $20M Sale Amid Market Turbulence
101 finance2026-03-19 14:48:59
HUMA’s Exclusive Saudi Deal and 25% Share Price Cut: A Sign of Urgency or a Strategic Move?
101 finance2026-03-21 15:27:43
Humacyte’s Strategic Approach: Fundraising and Middle East Momentum Reduce Risks of Binary Clinical Results
101 finance2026-03-22 04:39:50
HUMA: Saudi Exclusive Period and Phase 3 Results Present High-Stakes, High-Confidence Triggers
101 finance2026-03-22 05:00:39
Humacyte Appoints Rick McElheny as Senior Vice President of Business Development
Finviz2026-03-26 12:03:47
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update
Finviz2026-03-27 11:03:57
Humacyte, Inc. (HUMA) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations
101 finance2026-03-27 13:15:40
Humacyte’s VAC Approval Timelines and Pricing Claims Don’t Match in 2025 Earnings Calls
101 finance2026-03-29 06:27:53
Humacyte, Inc. (HUMA) Shares Decline Despite Overall Market Rise: The Reason Explained
101 finance2026-04-01 23:18:49
HUMA Rebounds Close to Support Level—Yet Trading Volume Stays Low
101 finance2026-04-02 19:33:47
HUMA stock chart
HUMA stock detailsHUMA stock price change
On the last trading day, HUMA stock closed at 0.64 USD, with a price change of 8.53% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more